Skip to main content

Advertisement

Log in

Thyroid nodule recurrence following lobo-isthmectomy: incidence, patient’s characteristics, and risk factors

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

This study was aimed at assessing the incidence and timing of thyroid nodules recurrence, defined as appearance of new benign or malignant nodules in contralateral lobe in patients with benign thyroid nodules or thyroid microcarcinoma treated with lobo-isthmectomy. Patient’s characteristics and risk factors associated with this phenomenon were also investigated.

Methods

A retrospective study was performed by evaluating 413 patients undergoing lobo-isthmectomy with a minimum follow-up of 1 year. Clinical characteristics, surgical interventions and complications, histological diagnosis, and thyroid function at last follow-up were collected.

Results

Single or multiple thyroid nodule recurrence equally occurred in 80 patients (23%) with a median time to relapse of ~ 5 years (range 0.3–34.5 years) after lobo-isthmectomy. Recurrence was significantly associated with younger age (< 46 years) and number of pregnancies in women. Development of hypothyroidism was not rare either (~ 10%) and appeared in 3–19 months; a preoperative TSH level > 2.43 mIU/L was associated with the need of l-thyroxin replacement therapy after surgery. The most frequent surgical complication was transient hypoparathyroidism (4.6%), while the rate of permanent hypoparathyroidism significantly increased in patients submitted to completion thyroidectomy (5.3%).

Conclusions

Thyroid nodules recurrence following lobo-isthmectomy is not a rare event and occurs within 5 years after surgery, more frequently in younger patients with family history of nodular goiter and in women with multiple pregnancies. Pre-surgical TSH levels may predict the development of post-surgical hypothyroidism, possibly improving the management of patients addressed to surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Filetti S, Durante C, Torlontano M (2006) Nonsurgical approaches to the management of thyroid nodules. Nat Clin Pract Endocrinol Metab 2:384–394. https://doi.org/10.1038/ncpendmet0215

    Article  PubMed  Google Scholar 

  2. Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537–540

    Article  CAS  Google Scholar 

  3. Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493

    Article  CAS  Google Scholar 

  4. Lamartina L, Deandreis D, Durante C, Filetti S (2016) ENDOCRINE TUMOURS: imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach. Eur J Endocrinol 175:R185–R202. https://doi.org/10.1530/eje-16-0088

    Article  CAS  PubMed  Google Scholar 

  5. Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226–231

    Article  CAS  Google Scholar 

  6. Guth S, Theune U, Aberle J et al (2009) Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Investig 39:699–706. https://doi.org/10.1111/j.1365-2362.2009.02162.x

    Article  CAS  Google Scholar 

  7. Jiang H, Tian Y, Yan W et al (2016) The prevalence of thyroid nodules and an analysis of related lifestyle factors in Beijing communities. Int J Environ Res Public Health 13:442. https://doi.org/10.3390/ijerph13040442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133

    Article  Google Scholar 

  9. Rosato L, Avenia N, Bernante P et al (2004) Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 28:271–276. https://doi.org/10.1007/s00268-003-6903-1

    Article  PubMed  Google Scholar 

  10. Bellantone R, Lombardi CP, Boscherini M et al (2004) Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis. Surgery 136:1247–1251. https://doi.org/10.1016/j.surg.2004.06.054

    Article  PubMed  Google Scholar 

  11. Akkari M, Schmitt D, Jeandel C et al (2014) Nodular recurrence and hypothyroidism following partial thyroidectomy for benign nodular thyroid disease in children and adolescents. Int J Pediatr Otorhinolaryngol 78:1742–1746. https://doi.org/10.1016/j.ijporl.2014.07.037

    Article  CAS  PubMed  Google Scholar 

  12. Lytrivi M, Kyrilli A, Burniat A et al (2016) Thyroid lobectomy is an effective option for unilateral benign nodular disease. Clin Endocrinol (Oxf) 85:602–608. https://doi.org/10.1111/cen.13088

    Article  CAS  Google Scholar 

  13. Hima S, Sreeja S (2016) Modulatory role of 17β-estradiol in the tumor microenvironment of thyroid cancer. IUBMB Life 68:85–96. https://doi.org/10.1002/iub.1462

    Article  CAS  PubMed  Google Scholar 

  14. Derwahl M, Nicula D (2014) Estrogen and its role in thyroid cancer. Endocr Relat Cancer 21:T273–T283. https://doi.org/10.1530/ERC-14-0053

    Article  CAS  PubMed  Google Scholar 

  15. Moleti M, Sturniolo G, Di Mauro M et al (2017) Female reproductive factors and differentiated thyroid cancer. Front Endocrinol 8:111. https://doi.org/10.3389/fendo.2017.00111

    Article  Google Scholar 

  16. Krohn K, Führer D, Bayer Y et al (2005) Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504–524. https://doi.org/10.1210/er.2004-0005

    Article  CAS  PubMed  Google Scholar 

  17. Greig WR, Boyle JA, Duncan A et al (1967) Genetic and non-genetic factors in simple goitre formation: evidence from a twin study. Q J Med 36:175–188

    CAS  PubMed  Google Scholar 

  18. Bignell GR, Canzian F, Shayeghi M et al (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123–1130. https://doi.org/10.1086/301610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Neumann S, Willgerodt H, Ackermann F et al (1999) Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I− symporter. J Clin Endocrinol Metab 84:3750–3756. https://doi.org/10.1210/jcem.84.10.6023

    Article  CAS  PubMed  Google Scholar 

  20. Capon F, Tacconelli A, Giardina E et al (2000) Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet 67:1004–1007. https://doi.org/10.1086/303095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ye L, Zhou X, Huang F et al (2017) The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing. Nat Commun 8:15533. https://doi.org/10.1038/ncomms15533

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Knobel M (2016) Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters. J Endocrinol Investig 39:357–373. https://doi.org/10.1007/s40618-015-0391-7

    Article  CAS  Google Scholar 

  23. Grani G, Bruno R, Lucisano G et al (2017) Temporal changes in thyroid nodule volume: lack of effect on paranodular thyroid tissue volume. Thyroid 27:1378–1384. https://doi.org/10.1089/thy.2017.0201

    Article  PubMed  Google Scholar 

  24. Vasica G, O’Neill CJ, Sidhu SB et al (2012) Reoperative surgery for bilateral multinodular goitre in the era of total thyroidectomy. Br J Surg 99:688–692. https://doi.org/10.1002/bjs.8684

    Article  CAS  PubMed  Google Scholar 

  25. Kurmann A, Herden U, Schmid SW et al (2012) Morbidity rate of reoperation in thyroid surgery: a different point of view. Swiss Med Wkly 142:w13643. https://doi.org/10.4414/smw.2012.13643

    Article  PubMed  Google Scholar 

  26. Verloop H, Louwerens M, Schoones JW et al (2012) Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab 97:2243–2255. https://doi.org/10.1210/jc.2012-1063

    Article  CAS  PubMed  Google Scholar 

  27. Kandil E, Krishnan B, Noureldine SI et al (2013) Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Oto-Rhino-Laryngol Its Relat Spec 75:6–17. https://doi.org/10.1159/000345498

    Article  CAS  Google Scholar 

  28. Grani G, Carbotta G, Nesca A et al (2015) A comprehensive score to diagnose Hashimoto’s thyroiditis: a proposal. Endocrine 49:361–365

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

GG and LL contributed to this paper as recipients of the PhD program of Biotechnologies and Clinical Medicine of the University of Rome, Sapienza.

Corresponding author

Correspondence to M. C. Zatelli.

Ethics declarations

Conflict of interest

The authors declare they have no conflict of interest that may influence the content of this manuscript.

Ethical approval

The authors declare that manuscript complies with the ethical standards indicated in the instruction for authors of the journal.

Informed consent

All patients provided permission for disclosing their anonymized data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zatelli, M.C., Lamartina, L., Meringolo, D. et al. Thyroid nodule recurrence following lobo-isthmectomy: incidence, patient’s characteristics, and risk factors. J Endocrinol Invest 41, 1469–1475 (2018). https://doi.org/10.1007/s40618-018-0946-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-018-0946-5

Keywords

Navigation